Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01397799
Show Display Options
Rank Status Study
1 Completed Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
Condition: Acute Myelogenous Leukemia
Intervention: Drug: KX2-391

Indicates status has not been verified in more than two years